A Convenient Injection Option:
Offered with Professional Care at Home
Convenience and Peace of Mind
When you're getting Sandostatin® LAR Depot (octreotide acetate for injectable suspension) therapy for carcinoid syndrome, you know how important it is to keep to your schedule and get your injections exactly as prescribed. That's why the Sandostatin® Nurse Home Injection Program was developed—to help make your life a little easier.
If your doctor recommends you as an appropriate patient to participate in the Program and you're eligible, you'll be able to receive your injections at home, administered by a specially trained registered nurse. To take advantage of this convenient way to receive your injections:
- Print the enrollment form and bring it to your doctor
- Find out from your doctor if you're a candidate for home injections and check if you're eligible
Advantages of the Sandostatin® Nurse Home Injection Program
- Convenient professional care. When you're dealing with diarrhea and flushing associated with carcinoid syndrome, the Program offers a convenient administration option, removing the stress of driving to the doctor's office and time spent in the waiting room.
- Injections planned around your schedule. You can make the most of your time by scheduling injections when it suits you because nurses are available outside traditional office hours, including weekends and evenings.
- A professional source of care. Your registered nurse will have the time to answer your treatment-related questions and report back to your doctor after each visit. You'll be receiving professional care in the comfort of your own home.
- Medicine you can trust. You'll have peace of mind not only from the professional care you receive from a specially trained nurse, but also from knowing your nurse will give you Sandostatin® LAR Depot:
- Over 4 million doses of Sandostatin® LAR Depot administered worldwide*
- Clinical experience supported by over 600,000 patient-years of experience,†over 6000 published articles,†and over 600 clinical trials†‡
*Sandostatin® LAR Depot for all indications.
†Combined use of immediate release Sandostatin® Injection and Sandostatin® LAR Depot for all indications.
‡Includes both ongoing and completed trials for all approved indications.
How the Sandostatin® Nurse Home Injection Program Works
Just Five Simple Steps to Receive Your Injections At Home
1. Your doctor recommends you for the program and submits your enrollment form
2. BioScrip®, the administrator of the program, verifies your eligibility
3. BioScrip® calls you to schedule your next injection at your convenience
4. A specially trained treatment nurse is assigned to you
5. Your treatment nurse visits your home and:
- Assesses your condition and notes any change in your status
- Gives the injection
- Makes the next appointment, following up with a reminder
- Sends a report to your doctor
Important Things to Know About the Nurse Home Injection Program
- The Program does not replace your doctor's care. It simply provides you with the convenience of receiving your injections at home. You should still go to your regular doctor check-ups.
- If you are new to Sandostatin® LAR Depot, your first dose must be received in your doctor's office.
- Depending on your insurance, your co-pay might change.
Finding Out if You're Eligible For the Program
The Sandostatin Nurse Home Injection Program is an additional benefit for all appropriate patients with diarrhea and flushing associated with carcinoid syndrome for whom Sandostatin® LAR Depot has been prescribed.
- Residents of all states except Massachusetts, Michigan, Minnesota, and Rhode Island can participate
- The Program is available to patients covered by most commercial plans (HMO, PPO, etc)
- Patients with government-provided medical insurance (eg, Medicare Part B and D, or Medicaid) are not eligible at this time
To Find Out if You're Eligible For the Program:
- Print the enrollment form and take it to your doctor
- Call 1-888-LAR-4759 (1-888-527-4759) and speak with a representative at BioScrip®, the Program administrator
Get Instant Answers to Your Questions
Click on the questions below for answers to Frequently Asked Questions (FAQs) about the Sandostatin® Nurse Home Injection Program.
- Am I eligible for this program based on my medical and pharmaceutical insurance coverage?
- According to my disease state, am I a candidate for this program?
- What are the main benefits of the Sandostatin® LAR Depot Nurse Home Injection Program?
- How flexible is the scheduling?
- How is my nurse selected?
- How does the Sandostatin® LAR Depot get to my home?
- Will I still see my doctor regularly?
- Does this involve a lot of paperwork on my part?
To print a complete list of questions and answers, click here.
Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is indicated for long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors and for the long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors in patients in whom initial treatment with immediate release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated.
Important Safety Information
As with immediate release Sandostatin® Injection, the most frequently reported drug-related adverse events were biliary disorders (62%), gastrointestinal disorders (14% to 38%), and injection-site pain (20% to 50%). Hypoglycemia (4%), hyperglycemia (27%), sinus bradycardia (19%), conduction abnormalities (9%), and arrhythmias (3%) have been reported.
The controlled clinical trials that support the marketing clearance for Sandostatin® LAR Depot did not include determination of effect on tumor size or rate of growth. Sandostatin® LAR Depot is not indicated for tumor shrinkage. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
